Cargando…
LJ-2698, an Adenosine A(3) Receptor Antagonist, Alleviates Elastase-Induced Pulmonary Emphysema in Mice
Emphysema, a major component of chronic obstructive pulmonary disease (COPD), is a leading cause of human death worldwide. The progressive deterioration of lung function that occurs in the disease is caused by chronic inflammation of the airway and destruction of the lung parenchyma. Despite the mai...
Autores principales: | Boo, Hye-Jin, Park, So Jung, Noh, Myungkyung, Min, Hye-Young, Jeong, Lak Shin, Lee, Ho-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216744/ https://www.ncbi.nlm.nih.gov/pubmed/32062956 http://dx.doi.org/10.4062/biomolther.2019.162 |
Ejemplares similares
-
LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice
por: Park, Jong-Gil, et al.
Publicado: (2018) -
Anti-obesity effects of the dual-active adenosine A(2A)/A(3) receptor-ligand LJ-4378
por: Kim, Kyungmin, et al.
Publicado: (2022) -
Regorafenib prevents the development of emphysema in a murine elastase model
por: Oh, Kwangseok, et al.
Publicado: (2023) -
Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema
por: Fujita, Tetsuo, et al.
Publicado: (2016) -
Inhibition of Elastase-Pulmonary Emphysema in Dominant-Negative MafB Transgenic Mice
por: Aida, Yasuko, et al.
Publicado: (2014)